1-20 of 41
Sort by
News

RedirecTT-1 Combo of Teclistamab and Talquetamab Suggests Efficacy in R/R MM

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, RedirecTT-1 Combo of Teclistamab and Talquetamab Suggests Efficacy in R/R MM
News

GPRC5D-Directed CAR T-Cell Therapy BMS-986393 Shows Potential for R/R MM

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, GPRC5D-Directed CAR T-Cell Therapy BMS-986393 Shows Potential for R/R MM
News

MRD-Adapted Treatment Identified Newly Diagnosed Patients with MM for Intensification, Cessation

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, MRD-Adapted Treatment Identified Newly Diagnosed Patients with MM for Intensification, Cessation
News

Efgartigimod Shows Long-Term Safety, Efficacy in Long-Standing Primary ITP

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, Efgartigimod Shows Long-Term Safety, Efficacy in Long-Standing Primary ITP
News

Rusfertide Effectively Supports Hematocrit Control in PV

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, Rusfertide Effectively Supports Hematocrit Control in PV
News

Non-Chemo Sequential Therapy Achieves High Remission in Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia

Anna Azvolinsky, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Non-Chemo Sequential Therapy Achieves High Remission in Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
News

Mid-July 2023 Data Stream

Published: 2023
Abstract
Mid-July 2023
View News titled, Mid-July 2023 Data Stream
News

BM MRD Status at One Month Post-CAR-T May Predict PFS in Patients with MM

Khylia Marshall
Published: 2023
Abstract
Mid-July 2023
View News titled, BM MRD Status at One Month Post-CAR-T May Predict PFS in Patients with MM
News

Bortezomib-Based Maintenance May Not Improve Outcomes for Patients With High-Risk MM Undergoing AHCT

Katie Robinson
Published: 2023
Abstract
Mid-July 2023
View News titled, Bortezomib-Based Maintenance May Not Improve Outcomes for Patients With High-Risk MM Undergoing AHCT
News

Relationship of MDS, Vulnerability, and Health-Related Quality of Life

Lara C. Pullen, PhD
Published: 2023
View News titled, Relationship of MDS, Vulnerability, and Health-Related Quality of Life
News

Genetic Profiling Can Optimize Value of Lenalidomide Maintenance in Patients With MM

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, Genetic Profiling Can Optimize Value of Lenalidomide Maintenance in Patients With MM
News

Interim PET-Guided Treatment for Early-Stage NLPHL

Lara C. Pullen, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Interim PET-Guided Treatment for Early-Stage NLPHL
News

Silent Cerebral Infarction During iTTP Can Affect Cognition

Lara C. Pullen, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Silent Cerebral Infarction During iTTP Can Affect Cognition
News

AbbVie Withdraws Two Accelerated Ibrutinib Approvals

Published: 2023
Abstract
Mid-July 2023
View News titled, AbbVie Withdraws Two Accelerated Ibrutinib Approvals
News

FDA Grants COVID-19 Antiviral Fast Track Designation

Published: 2023
Abstract
Mid-July 2023
View News titled, FDA Grants COVID-19 Antiviral Fast Track Designation
News

BLA Submitted for One-Time SCD Treatment

Published: 2023
Abstract
Mid-July 2023
View News titled, BLA Submitted for One-Time SCD Treatment
News

Biosimilar Use Increases, Cost Decreases

Published: 2023
Abstract
Mid-July 2023
View News titled, Biosimilar Use Increases, Cost Decreases
News

MajesTEC-2: Future of BCMA-targeted Bispecific, Gamma Secretase Inhibitor Combo in Question

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, MajesTEC-2: Future of BCMA-targeted Bispecific, Gamma Secretase Inhibitor Combo in Question
News

Fitusiran Significantly Reduces Bleeding Events, Improves HRQoL in Hemophilia A, B

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, Fitusiran Significantly Reduces Bleeding Events, Improves HRQoL in Hemophilia A, B
News

Mediastinal Radiotherapy Safe To Omit in PMBCL After Complete Metabolic Response

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, Mediastinal Radiotherapy Safe To Omit in PMBCL After Complete Metabolic Response